Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mikecz
    Junior Member
    • Jan 2012
    • 5

    #1

    Differential Expression across libraries/platforms

    I've been searching for a while now and I can't seem to find any kind of discussion on this topic.

    Is there any consensus on the most appropriate way (if any) to calculate differential expression of transcripts with samples derived from different library preparation methods or from different sequencing platforms?

    I have a few Illumina Hiseq 2000 100bp PE RNA-seq samples that can be considered biological replicates, but not quite technical replicates since some are from Truseq stranded libraries with others from Truseq unstranded preps. The problem is more complex yet since the unstranded samples have ~150 million read pairs and the stranded samples only 25 million.

    So far I've used the stranded reads for de novo transcriptome assembly, then used both the stranded and unstranded reads for mapping and quantification. Treating them in the same way by ignoring strand information with Bowtie and allowing for unpaired mapping when concordant mapping isn't possible gives me pretty horrible expression correlations after RSEM.

    Is there a normalization method that can compensate for the different biases in library preparation?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Just treat all of the samples as you would normally and treat the technology type/library-prep-kit as a batch variable (or two) in your model design.

    Of course, if whatever you're actually interested in measuring is partitioned across these then you're probably SOL.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...